Contact this company: 702-839-7200
How does the role of Mickael Flaa contribute to the CardioVascular BioTherapeutics executive team? With Hoover's you get up-to-date information on CardioVascular BioTherapeutics executives, officers, and board members. Executive biographies usually include recent work history, salary, career progression, and a review of other company affiliations. Salary and bonus are provided for CardioVascular BioTherapeutics executives when available.
CALL NOW or register below to learn how you can access all of CardioVascular BioTherapeutics's executive information.
Mickael A. Flaa is a consultant who has served as the Company's Treasurer, Vice President and Chief Financial Officer since June 2003, and has been a member of its Board of Directors since February 2005. He has held the position of Chief Financial Officer with Phage since June 2003. He has been a member of the Board of Directors for CPI since May 2005. He served as Interim Chief Financial Officer on a consulting basis for Breakaway Solutions, Inc., a public company, from February 2001 to 2002...
View more information on CardioVascular BioTherapeutics.
Buy the complete Hoover's company report on CardioVascular BioTherapeutics
Obtain a roster of the CardioVascular BioTherapeutics executives, and CardioVascular BioTherapeutics executive biographies. Executive data provided by Hoover's includes expansive lists of up to 200 key employees, officers, and board members per company. Name, title, salary, bonus, age, and biography are provided for company management when available.
Learn how to get full access to executives for over 28 million businesses.
